CRO ClinTec International has appointed Alastair MacDonald as Global Head of Clinical Operations. Alastair joins from AstraZeneca with almost 25 years' experience in clinical development, most recently as Global Medical Evidence and Observational Research Director at the company. As a Global Delivery Director within AstraZeneca, Alastair made key contributions to the development pipeline and commercialisation, with a focus on oncology, and within other key strategic areas including Cardiovascular, Metabolic and Respiratory Medicine. His significant oncology background includes recent contributions to the development and subsequent commercialisation of a number of key treatments across a broad range of cancer diseases.

Alastair was a Board Director of the Institute of Clinical Research (ICR), a premier organisation responsible for education, training and career development of clinical research professionals in the UK. In 2013 he was awarded an Honorary Fellowship of the ICR. Alastair's prior career includes the role of Regional Manager for SmithKline Beecham Pharmaceuticals (GlaxoSmithKline) ensuring clinical delivery for the UK local operating office, and at Leo Pharmaceuticals, where he specialised in the development of treatments for Dermatology and Pancreatic cancer.